Core Viewpoint - Yifan Pharmaceutical (002019) remains focused on its core business development and reports that operations are running smoothly, with management expressing confidence in future growth [1] Company Summary - The company is actively engaging with investors through interactive platforms, indicating a commitment to transparency and communication [1] - Management's confidence suggests a positive outlook for the company's strategic direction and operational performance [1]